Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,760
datasets available to search
ShareScore release 0.9.0
Dataset results
1,760 results for “phase 2”
A Phase I Study to Assess the Pharmacodynamics of Oral AR-C165395XX in Subjects With Type 2 Diabetes Mellitus (T2DM)
ClinicalTrials.gov study NCT02367066. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluation of Efficacy, Safety and Tolerability of Aldafermin in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study In Subjects With Nonalcoholic Steatohepatitis and Stage 2/
ClinicalTrials.gov study NCT03912532. IPD Sharing: NO. Countries: 2. Publications: 1.
Phase 2 Study: An Open-Label, Randomized, Phase 2 Dose-Finding Study of Pacritinib in Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post- Essential Thrombocythemia Myel
ClinicalTrials.gov study NCT04884191. IPD Sharing: Not stated. Countries: 8. Publications: 1.
A Phase 2 Study to Evaluate the Safety and Immunogenicity of Two Oral Poliovirus Vaccine Candidates
ClinicalTrials.gov study NCT04544787. IPD Sharing: NO. Countries: 1. Publications: 2.
Phase 2 Study to Evaluate the Oral Combination of Ixazomib (MLN9708) With Cyclophosphamide and Dexamethasone in Patients With Newly Diagnosed or Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02046070. IPD Sharing: YES. Countries: 5. Publications: 2.
Phase 2 Study of AUY922 in NSCLC Patients With Exon 20 Insertion Mutations in EGFR
ClinicalTrials.gov study NCT01854034. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Randomized Phase 2 Trial of TAS-114 in Combination With S-1 Versus S-1
ClinicalTrials.gov study NCT02855125. IPD Sharing: Not stated. Countries: 6. Publications: 1.
Phase 2 Study of VX-950, Pegasys®, and Copegus® in Hepatitis C
ClinicalTrials.gov study NCT00336479. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Phase 2b/3, Randomized, Observer-Blinded, Placebo-Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Ag
ClinicalTrials.gov study NCT04652102. IPD Sharing: Not stated. Countries: 10. Publications: 1.
A Phase-I Study of a Nanoparticle-based Peptide Vaccine Against SARS-CoV-2
ClinicalTrials.gov study NCT05113862. IPD Sharing: YES. Countries: 1. Publications: 1.
2 Phase Comparison of Pre-operative CT and PET Images for Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT01821105. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Randomized Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Pla
ClinicalTrials.gov study NCT01903993. IPD Sharing: Not stated. Countries: 13. Publications: 5.
Phase IIb Safety and Efficacy Study of Different Oral Doses of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01807221. IPD Sharing: Not stated. Countries: 25. Publications: 4.
An Open-Label Phase 2 Trial of Nanatinostat Plus Valganciclovir in Patients With EBV+ Relapsed/Refractory Lymphomas
ClinicalTrials.gov study NCT05011058. IPD Sharing: NO. Countries: 14. Publications: 2.
Phase 2 Study of the Combination of Bruton's Tyrosine Kinase Inhibitor PCI-32765 and Rituximab in High-Risk Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Patients
ClinicalTrials.gov study NCT01520519. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase 2 Study of SP-02L in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
ClinicalTrials.gov study NCT02653976. IPD Sharing: NO. Countries: 4. Publications: 1.
Phase 2 Study of Lovastatin as Breast Cancer Chemoprevention
ClinicalTrials.gov study NCT00285857. IPD Sharing: NO. Countries: 1. Publications: 1.
Giving Information Systematically and Transparently in Lung and GI Cancer Phase 2
ClinicalTrials.gov study NCT04179305. IPD Sharing: NO. Countries: 1. Publications: 43.
A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Vs Placebo for Symptomatic Treatment in Patients With Huntington's Disease
ClinicalTrials.gov study NCT02006472. IPD Sharing: Not stated. Countries: 12. Publications: 4.
A Phase 2 Clinical Study in Subjects With Primary Progressive Multiple Sclerosis to Assess the Efficacy, Safety and Tolerability of Two Oral Doses of Laquinimod Either of 0.6 mg/Day or 1.5mg/Day (Expe
ClinicalTrials.gov study NCT02284568. IPD Sharing: Not stated. Countries: 10. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.